NCT07424872 Project VERANDA: Requirement Analysis Survey
| NCT ID | NCT07424872 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Berlin Institute of Health @ Charité |
| Condition | Observational Study |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-13 |
| Primary Completion | 2026-05-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-05-13 with a primary completion date of 2026-05-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Between 0.6% and 22.2% of the global adult male population has a sexual interest in children (SIIC), depending on evaluation methods \[1\]. SIIC constitutes a major risk factor for child sexual abuse (CSA) and viewing of child sexual abuse material (CSAM). The true rates of CSA offences cannot be estimated, but self-report studies find 30 times higher rates of child-reported CSA compared to reports from child protection services or police. Engagement in therapy is a protective factor against the risk of child sexual abuse and can lead to reductions in CSAM consumption and severity. Anticipated negative therapist behaviour is associated with less willingness to seek treatment. The fear of being reported by the therapist discourages participation in therapy, a concern complicated by mandatory reporting laws in some countries. Negative attitudes towards ISIC are high, and SIIC may be the most stigmatised trait globally. Identifying barriers to treatment for ISIC, and of measures to overcome them, is important to increase therapy engagement, with the goal to improve wellbeing, reduce CSAM consumption, and reduce the risk of CSA offences. Patient anonymity during therapy may play an important role in increasing disclosure of stigmatised traits. It remains unclear whether anonymous therapy addresses patient treatment anxieties and therefore increases the comfort or willingness to engage in therapy. To address this research gap, we conduct an anonymous online survey with ISIC to answer the following questions: RQ1. Can online therapy preferences be identified for minor-attacted individuals and for their therapists? RQ2. Are there individual factors that predict stigmatized individuals' online therapy preferences? (E.g. Trust, Self-Stigma) RQ3. Are there differences between the different stigmatized groups', therapists, and general populations' online therapy preferences?
Eligibility Criteria
Inclusion Criteria: * Belonging to one of the target groups. * Otherwise, for general members of the public, none. Exclusion Criteria: * Younger than 18
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07424872 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Observational Study. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07424872 currently recruiting?
Yes, NCT07424872 is actively recruiting participants. Contact the research team at maija.poikela@bih-charite.de for enrollment information.
Where is the NCT07424872 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT07424872 clinical trial?
NCT07424872 is sponsored by Berlin Institute of Health @ Charité. The trial plans to enroll 100 participants.